The Speculator

Viralytics expands its cancer targets ... and is expanding its capital base.

PORTFOLIO POINT: Viralytics expands cancer targets ... and international biotech analyst gives company an enthusiastic wrap.

Cancer cure hopeful Viralytics (VLA), now in the middle of a share purchase plan that closes on Friday, this week announced a further expansion of clinical trials on a wider range of cancer sufferers.


SMS Code Sent…

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to activate your membership

If you didn't receive SMS code please

Log in to access this content

Looks you are already a member. Please enter your password to proceed

Hi {{ user.FirstName }}

Verify your mobile number to unlock a FREE trial

Looks like you've already taken a free trial

Please sign up for full access

Updating information

Please wait ...

Related Articles